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ABSTRACT
Objectives The objective of this survey was to investigate 
the barriers, facilitators, expectations and patient 
preferences regarding joint protection (JP) programmes in 
people with hand arthritis.
Design Cross- sectional survey.
Setting Tertiary clinic.
Participants Patients with hand arthritis: osteoarthritis, 
rheumatoid arthritis, psoriatic arthritis and other forms of 
arthritis.
Primary and secondary outcome measures This 
study used a survey among people with hand arthritis. 
Descriptive statistics and percentages were reported for 
all the data about the barriers, facilitators and preferences 
around JP.
Results A total of 192 patients consented to participate. 
Most of the patients (82%) were unaware of JP. Factors 
that may act as barriers to participation and were regarded 
as ‘a very big concern’ were: cost of the programme 
(44%), time of offering the programme (39%), work 
commitments (36%) and having a centre/clinic close to 
the house (28%). Factors that may act as facilitators and 
rated as ‘extremely helpful’ were: research that shows 
that JP works (26%) and having the centre/clinic close to 
the house (25%). An online format for JP was the most 
preferred option (54%). Half (46%) preferred a timeframe 
of 1 hour, three times per week and 44% preferred a 2- 
hour programme, for three times per week.
Conclusions Awareness of the potential benefits of JP, 
and prior experience with JP programme were very low. 
Common potentially modifiable patient- reported barriers to 
participate in future JP interventions, included: cost, work 
commitments, distance from home to clinic and times that 
the intervention were provided. These barriers might be 
addressed with free and accessible forms of delivery of 
JP, which may lead to better uptake and participation in JP 
programmes.
INTRODUCTION
Osteoarthritis (OA) is characterised as a 
degenerative joint disease that affects approx-
imately 27 million adults in the USA and is 
one of the leading causes of disability.1 Osteo-
arthritis affects 60% to 70% of the popula-
tion above the age of 65 years, and is likely 
to increase further in the future, due to the 
ageing population.2 3 The most common site 
of OA is the hand and it typically involves 
the interphalangeal (proximal and distal) 
and first carpometacarpal joints.4 In a clin-
ical setting, pain is a major symptom among 
patients with hand OA as it contributes to a 
reduction in joint function.1 4 Currently there 
is no cure for hand OA, but goals of treatment 
include maximising long- term health- related 
quality of life, by controlling symptoms such 
as pain, prevention of structural damage and 
normalisation of function.5
Joint protection (JP) is a self- management 
strategy for patients living with arthritis to 
help preserve joint function and reduce 
pain.6 JP involve training on ‘safer move-
ment patterns, the use of adaptive devices 
(eg, built up handles, hands free technol-
ogies) and behaviour modifications (eg, 
activities to avoid, pacing) during physical 
activity.6 However, JP can be implemented 
in many different ways, and patient prefer-
ences are rarely reported as being consid-
ered in programme design. There are many 
unknown barriers that may reduce partici-
pation in JP programmes, and these may be 
related to personal beliefs, preferences or 
Strengths and limitations of this study
 ► The survey was adapted to people with hand ar-
thritis from a validated questionnaire developed to 
assess the barriers, facilitators and preferences to 
exercise used in other clinical populations.
 ► A small sample of people with experience of joint 
protection prevented us from adequately exploring 
the perceptions of patients who had completed the 
programme.
 ► The survey was designed for English speakers with 
hand arthritis therefore, people speaking other lan-
guages were not represented.
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circumstances. For example, patients may believe that 
JP will not slow joint damage, may not like engaging 
in groups or may have life/location issues that make it 
difficult to attend clinics. Identifying these barriers at 
group and individual levels may be a strategy to design 
and customise future JP to increase participation in JP 
programmes.
Considering preferences and customising JP may be 
critical to improving adherence. Prior reports suggest 
that adherence is a major concern. Previous systematic 
review and meta- analysis indicated that only 6 out of the 
17 trials used strategies to maximise adherence for JP.7 
Although the evaluation of adherence from these trials 
was ranging from low- to- moderate adherence has not 
been properly studied in the published literature yet. The 
purpose of this cross- sectional survey is to investigate the 
barriers, facilitators, expectations and patient preferences 
regarding JP programmes in people with hand arthritis.
METHODS
Patient and public involvement
Patients or the public were not involved in the design, 
or conduct, or reporting, or dissemination plans of our 
research.
Study design
This study used a cross- sectional survey among people 
with hand arthritis that was open for response from 
March 2019 to February 2020.
Inclusion criteria and exclusion criteria
Participants were eligible to complete the anonymised 
survey if they were able and willing to provide informed 
consent, were between 18 to 85 years old, they have been 
diagnosed with hand arthritis and they could read and 
write English. Participants which have not been diag-
nosed with hand arthritis or they could not answer the 
survey questions, or they did not understand English were 
excluded from the study.
Setting and recruitment
Participants were recruited through advertisements in 
the main website of The Arthritis Society of Canada and 
from the Roth McFarlane Hand and Upper Limb Centre 
(HULC) at St. Joseph’s Health Care Hospital in London, 
Ontario. Research assistants and research coordinators 
from HULC contacted people with hand arthritis who had 
previously expressed interest in participating in research. 
Also, an informative poster was setup at HULC patient 
waiting area providing details about the study. Two sepa-
rate approaches were used for data collection: an online 
form to complete the survey and a paper- based version 
of the survey form at HULC clinical research laboratory.
Data protection
No participant identifying information was collected in 
this anonymised survey. Data were kept at the HULC clin-
ical research laboratory where only authorised personnel 
have access, and all paper- based files were stored in a 
locked cabinet. Electronic files were stored in encrypted 
file and apart from the study investigators no other person 
had access to the electronic records.
Survey
The survey was adapted to people with hand arthritis 
based on previous experience of the study investigator 
(JCM) with JP, from a validated questionnaire initially 
developed to assess the barriers, facilitators and prefer-
ences to exercise for people with osteoporosis and for 
shoulder arthritis.8 9 The survey consisted of 31 questions 
with sections related to barriers, facilitators, expectations 
and patient preferences for JP programmes in people 
with hand arthritis. The survey questions are presented in 
the online supplemental web appendix.
Data analysis
Quantitative
Descriptive statistics and percentages were reported for 
all the data about the barriers, facilitators and preferences 
around JP programmes. In 2014 (Statistics, Canada), 
16.5% of Canadians (around 4.8 million people) reported 
that they had been diagnosed with any form of arthritis by 
a health professional. The Ontario province represents 
the 18.5% of 4.8 million which is 888 000 individuals with 
arthritis approximately. Sample size calculation was based 
on a population size of 888 000 individuals, a confidence 
level of 95% and with 7% margin of error and it was deter-
mined that 196 individuals were needed to complete the 
survey.10 Data analyses were completed using Stata V.16.0.
Qualitative
Some of the survey questions (Questions 7, 8, 10, 11, 12, 
13) were written responses. For these questions qualitative 
data analyses techniques were used. Data were analysed by 
response line to identify emerging codes. Relationships 
and similarities among codes were discussed leading to 
the formation of themes. Themes were particularly iden-
tified to provide new information to the quantitative 
responses, in an effort to better understand the barriers 
and facilitators to use of JP programmes.11–13
RESULTS
A total of 192 patients consented to participate and 
completed our survey. They provided information about 
JP barriers and facilitators regarding their possible 
prospective participation in a JP programme, the impact 
of JP programmes on domains of their everyday life and 
their preferred frequency of use of JP. Out of the 192 
survey respondents, 92 (50%) were diagnosed with rheu-
matoid arthritis (RA) in the hand, 38 (21%) with hand 
OA, 29 (16%) with psoriatic arthritis (PsA), 13 (7%) had a 
diagnosis other than hand arthritis and 10 (5%) reported 
none from the options provided. The majority of partici-
pants were aged between 34 to 54 years old representing 
the 53% of the sample of this survey. Thirteen (n=13) 
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people disqualified from the survey, because 3 of them 
were under 18 years old and 10 of them had arthritis in 
lower extremities and therefore, they were deemed ineli-
gible to participate. The demographic description of the 
included sample is presented on table 1.
Awareness of joint protection programmes
Regarding patients’ awareness of JP programmes, from 
the 164 patients in total who had hand arthritis, most 
(82%) had never heard about JP programmes before, 
11% had heard about JP but had never taken part in 
such a programme. A small percentage of respondents 
(5%) had previously taken part in a JP and only 4% were 
currently participating in a JP programme. Among the 
13 participants who took part in JP, 5 people participated 
in a programme in an outpatient hospital department, 3 
at a family’s physician office, 2 in an inpatient unit, 2 in 
a rehabilitation centre and 1 home. The JP programme 
was provided most commonly by an occupational thera-
pist (46%), a family physician or specialist (38%) and to a 
lesser extent by a physiotherapist (15%) (table 1).
Use, frequency and perceived impact of joint protection 
programmes on outcomes
Out of 13 patients who participated in a JP programme, 5 
of them continued using the principles of the programme 
at least once a week, 4 of them kept using them always, 1 
participant applied them less than once a week while 3 of 
them did not use them at all. In table 2, 4 patients that 
participated in the joint protection provided examples 
what joint protection principles they used. Within this 
small subsample of 10 patients’ experiences (figure 1), 
8 patients reported ‘no change’ to ‘very much better’ in 
terms of impact on stiffness, pain, grip strength, hand 
function and swelling. Two patients reported feeling 
slightly worse to much worse in stiffness, pain, grips 
strength, hand function and swelling (figure 1).
Table 1 Sample characteristics
Variable % n
Age (years)
  18–24 3% 5
  25–34 11% 19
  35–44 26% 45
  45–54 26% 45
  55–64 23% 39
  65–74 7% 12
  75–84 1% 2
Diagnosis (hand) 182
  Osteoarthritis 22% 38
  Rheumatoid arthritis 51% 92
  Psoriatic arthritis 16% 29
  Other form of arthritis 7% 13
  None of the above 5% 10
Joint protection
  I am currently taking part in a joint 
protection programme
4% 6
  I have previously taken part in a joint 
protection programme
5% 7
  I have heard about joint protection but 
have not taken part in a programme
10% 17




  Inpatient - rehabilitation unit 8% 1
  Inpatient - hospital 8% 1
  Outpatient - hospital 38% 5
  Home care 8% 1
  A rehabilitation centre/clinic 15% 2
  Family physician 23% 3
Joint protection provider
  Family physician or specialist 38% 5
  Occupational therapist 46% 6
  Physiotherapist 15% 2
Table 2 Examples provided of joint protection principles 
reported by patients that used them
Example 1 ‘Learnt how to do things safer for my hands, re- 
enforced pacing’
Example 2 ‘Wearing thumb caps for working in the garden, 
wrist guards while using my hands. Splints for 
hands and feet’
Example 3 ‘I choose to use larger muscles and joints to aid 
me in completing day- to- day tasks, and I use 
splinting to reduce pain, weakness and fatigue’
Example 4 ‘I wore resting splints for 30 years. I have a 
key turner and a right- angled knife. I try to 
always use the largest joints. My taps and light 
switches are modified. I changed my cupboard 
handles. I use lightweight plates and an electric 
toothbrush’
Figure 1 Individuals who took part into joint protection 
(n=10) where asked to what extent did the joint protection 
(JP) affect stiffness, pain, grip strength, hand function and 
swelling. Only 2 out of 10 individuals that participated in JP 
experienced slightly worse to much worse outcomes.
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Information and awareness of the existence of joint protection 
programmes
The majority of the respondents have never heard about 
joint protection programmes until they undertook this 
survey, according to their comments in an open- ended 
question within the survey. None were informed about 
the existence of the joint protection programmes by a 
family physician or a local community centre. A small 
percentage of 14% were informed by a specialist about 
the existence of the JP programmes, 10% of them heard 
it from television, 5% by their therapist and 3% from 
family or friends.
Factors affecting prospective participation in joint protection
Factors reported by 87 participants that were reported 
as important barriers to participation in a future JP are 
described in figure 2. Factors that may act as barriers to 
participation and were regarded as ‘a very big concern’ 
included: cost of the programme (44%), time of offering 
the programme (39%), work commitments (36%) and 
having a centre/clinic close to the house (28%). Factors 
that may act as facilitators to participation and rated as 
‘extremely helpful’ were: research that shows that joint 
protection works (26%) and having the centre/clinic 
close to the house (25%). All the barriers and facilitators 
that may affect participation are presented in figure 2.
Qualitative data
A total of 73 participants provided additional information 
in open- ended responses to describe their barriers and 
facilitators to engaging in a JP programme. Three major 
themes emerged: personal factors; environmental factors; 
and health factors. For the personal factors, common 
barriers were energy, other personal or work commit-
ments and fear of further injury. Environmental factors 
included having a centre close to the house, transporta-
tion, cost of the programme, building accessibilities and 
social support from family or friends to participate with. 
Health factors included comorbidities associated with the 
disease, complications related to the disease, flare ups 
and depression. For example, one participant noted that 
arthritis- related health issues limited participation: RA 
said ‘[permanent] RA voice loss, [permanent] RA lung 
damage’, and another patient mentioned ‘flare ups’.
Facilitators mentioned in open- ended responses 
included: having the centre/clinic close to my house, trans-
portation to the centre where programme is provided, 
cost of the programme, time when the programme was 
offered, my work commitments, my personal commit-
ments, support from family/friends, having a friend to 
participate with, research that shows joint protect works 
and another patient finding joint protection helpful. 
A number of the barriers mentioned in open- ended 
responses related to health factors not specifically iden-
tified on the survey: flare ups, fear of further injury and 
comorbid conditions were not listed as potential barriers 
in the survey.
Preference on method of delivery of joint protection
An online format for JP was the most preferred option 
representing slightly over half of the respondents (54%). 
Among the remaining respondents there were prefer-
ences for at home (20%), clinic (17%), videos (6%) and 
printed material (2%). Patient were open to a variety of 
health providers for JP programmes, and stated prefer-
ence for occupational therapists (22%), physiotherapists 
(20%), family physician or specialists such as rheumatol-
ogists (19%), hand therapists (17%), other patients with 
arthritis (13%) and kinesiologists with the other choices 
comprising 2%.
Preference of frequency of joint protection
Participants reported their top preference in terms of 
frequency and their possible prospective participation in 
a JP. Half of them (46%) preferred a timeframe of 1 hour, 
three times per week for 10 weeks and 44% preferred a 
2- hour, three times a week for 5 weeks programme.
Usefulness of joint protection components
Patient preferences for content in JP suggest that infor-
mation about joint loading, reduction of joint stress, feed-
back on correctness and carefulness in tasks, information 
about pacing activities, advice from health professionals 
or other patients and demonstration of how to do things 
in ways that minimise effort and maximise efficiency, a JP 
programme were considered as moderately- to- extremely 
useful (figure 3). Respondents indicated that the 
following information would be moderately or extremely 
useful: activity pacing and how joint positions affect joint 
loading, ways to reduce joint loading and feedback on 
task performance. They indicated preference as ‘moder-
ately’ or ‘extremely useful’ the following approaches: 
advice from health professionals, demonstrations/feed-
back on task performance and advice from other patients 
(figure 3).
Perceived importance of joint protection programmes
Patients rated the following potential outcomes of JP 
as ‘extremely important’: pain reduction (92%), joint 
deformity prevention (83%), hand function (82%) 
and grip strength (75%). On average 84 out of 192 of 
patients reported how often they use one or more of the 
following rehabilitation modalities such as heat, cold, 
Figure 2 Factors perceived either as facilitators or barriers 
that may affect participation in a joint protection programme.
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exercise, joint protection, splints and modified equip-
ment (figure 4). Modalities such as heat, exercise and 
splints were reported that were used ‘very frequently’ by 
15% of the respondents. Heat (32%), exercise (25%) and 
cold modalities (19%) were used as ‘frequently’ by the 
participants. On the other hand, modalities such TENS/
electrical devices (68%), splints (46%), joint protection 
(48%) and modified equipment (43%) were never used 
by the respondents (figure 4).
DISCUSSION
This study found that very few patients with arthritis were 
aware of or had participated in a JP programme, yet 
slightly more than half favoured a JP programme which 
could be offered three times per week at 1 to 2 hours 
of engagement in an online format. This suggests a 
profound need for better accessibility to JP programmes 
for people with arthritis as a component of their overall 
self- management strategy.
It is also clear one single method of delivery is unlikely 
to meet all needs since variation in preferences was clear. 
An online format for JP was the most preferred option 
representing slightly over half of the respondents (54%). 
Other preferred options were JP programmes that could 
be completed at home (21%) or at a clinic (16%). Our 
findings need to be tempered by two considerations. 
First, some of the other preferred options overlap, for 
example, preferences like ‘at home’ or ‘videos’ could 
include virtual components. Second, since the majority 
of the respondents (82%) were unaware of JP and were 
rarely using it, their preferences were based on a priori 
assumptions not on experience with such programmes. 
However, preferences prior to participation are important 
since this is the time when patients make decisions about 
participation.
It was remarkable that so few respondents had partic-
ipated in JP programme, given that there is systematic 
review evidence demonstrating the effectiveness of these 
programmes both for patients with RA and OA.14 The 
included trials in this meta- analysis were of low meth-
odological quality however, the effects of JP on function 
outcomes for people with RA in the hand were benefi-
cial. In the few people who have used JP in our survey the 
experiences were mostly positive in terms of perceived 
benefit in symptom control and very limited perceived 
harm. Lack of awareness of JP programme was greater 
than anticipated and may reflect a lack of access to 
programmes, a lack of awareness in clinicians who should 
be recommending JP programme or a lack of interest in 
participating. Self- management strategies are important 
for patients with arthritis since it is a chronic disease. In 
fact, many of the patients in this survey were participating 
in some aspect of self- management. JP effectiveness has 
been supported by systematic reviews.6 7 14 Therefore, 
our finding that only 10 had participated in suggests that 
there is a substantial gap in awareness, delivery and acces-
sibility of these programmes.
Respondents identified several challenges to partici-
pate in JP programmes. This suggests that flexibility in 
how/when programmes are offered is a critical factor in 
programme planning. Patients placed high importance 
on participation in JP if research findings show that this 
programme actually works. Pain reduction outcomes, 
joint deformity prevention, hand function and grip 
strength outcomes were all judged as being ‘extremely 
important’ by the patients. Since all of these outcomes 
are important to patients it would be that adherence to 
JP could be improved by clear explanations of how JP 
can benefit each of these outcomes both a conceptual 
level and with the current research evidence that suggests 
benefits to these outcomes.
The level of participation preferred by potential partic-
ipants in JP in this study equates to 3 to 6 hours per week, 
and is similar to that performed in clinical trials of JP in 
patients with OA and RA in the hand.15–17 Half of the 
respondents ranked the online format as the first choice 
over all the other methods of delivery of JP with home 
programme being the second most preferred choice. This 
finding is consistent with a recent study where patients 
with RA reported that a home version of a hand exercise 
programme, which was held online was very useful and 
authors suggested that this might contribute to better 
adherence in long- term.18 Data from an randomised 
controlled trial of behavioural and hand exercises inter-
ventions in women with arthritis also suggested home 
programmes may increase participation.19 The recent 
pandemic has forced many countries to re- evaluate 
how care is delivered to maintain social distancing or 
self- isolation.20 The pandemic has heightened the lack 
of access to care for people with arthritis as this care is 
Figure 3 Participants were asked to rate the following 
components of joint protection from ‘extremely useful’ to 
‘extremely useless’.
Figure 4 Individuals were asked how often they used the 
following modalities to manage their symptoms.
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considered non- essential. At the same time, it has opened 
up the pathway for innovation and acceptance of alter-
native delivery models that provide remote accessibility. 
Since our data was collected pre- pandemic, we can only 
assume that preference for online programmes would 
have increased. While the efficacy of JP interventions 
with hand exercises has been evaluated it is difficult for 
patients with hand arthritis to have confidence that an 
online or remote intervention is equally effective method 
to control their symptoms without being tested in future 
trials.7 This underlines the importance of trials and post- 
trial implementation studies to provide more definitive 
evidence on the impact of virtual JP programmes.
The third most preferred choice of JP delivery was at the 
clinic. Our previous studies of information access pref-
erences in patients with fibromyalgia21 22 indicated that 
face- to- face interaction with healthcare providers was the 
most preferred way of getting information and it is likely 
that this is the positive aspect for attending a clinical site. 
Previous review has indicated that patient- centred inter-
action styles related to the provision of emotional support 
and allowing patient involvement in the consultation 
process may enhance the therapeutic alliance between 
clinician and patient.23 Effective communication between 
the clinician and the patient relies on verbal but also on 
non- verbal factors, and this can usually be achieved in an 
in- person encounter.24 The value of face- to- face interac-
tion may mean that online interventions although theo-
retically more accessible, may not instigate the same level 
of engagement or adherence.
Another key finding of this study is that the cost of 
the JP programme, working commitments, the time that 
JP is offered as well as the distance from home to clinic 
were regarded as the main barriers and could substan-
tially decrease participation in JP. Financial burden and 
time have been previously described for patients with RA 
as a perceived barrier.25 26 From the qualitative analysis 
barriers associated with health factors were novel, and not 
well captured in the survey.
Respondents identified a variety of perceived important 
outcomes with pain reduction, joint deformity prevention 
and hand function being the main predominant ones. 
This is consistent with the core set outcome measures 
that has been proposed from OMERACT - Osteoarthritis 
Research Society International (OMERACT- OARSI) set 
of responder criteria.27 Clinical outcomes for hand OA 
such as aesthetic damage in the joints and measured 
performance and function have been recommended 
by patients.28 29 Based on patients’ perceived benefit, 
JP programmes appeared to have neutral- to- positive 
impact on stiffness, pain, grip strength, hand function 
and swelling. While this is consistent with a recent meta- 
analysis7 14 there was a very low number of respondents 
that used JP in our sample.
Our study has several limitations that need to be 
taken into account when interpreting our study find-
ings. Since the survey was designed for English speakers 
with hand arthritis, people speaking other languages 
were not represented. Potentially cultural, language 
and health system issues could affect preferences. The 
survey responses were recorded online, and patients did 
not have access to electronic devices could not partici-
pate in the survey. However, we offered a paper version 
survey for individuals as an alternative. Finally, the small 
sample of people with experience of JP prevented us from 
adequately exploring the perceptions of patients who had 
completed the training.
Future research and clinical implications
While this survey is a first step to understand what factors 
affect participation rates in people who are candidates 
for JP, studies that collect patient perceptions of draft 
programmes in a co- design process are needed to create 
a patient- preference based JP programme. It is possible 
that preferences will change or become more specific 
through a co- design process. A future trial to compare 
alternative delivery models is highly needed. Our survey 
identified principles of JP that the patients perceived as 
extremely important and it is unclear if these compo-
nents were present in the published efficacy trials, since 
these studies have inadequate reporting.7 Adherence to 
guidelines such as Template for Intervention Description 
and Replication (TIDieR) and presentation of theoret-
ical assumptions for the content of programmes would 
improve fidelity across studies and in converting current 
JP programmes to online formats.30 One of the most 
important findings of our work is the lack of awareness 
about, and participation in JP in a sample of people for 
who current best evidence suggest this would be effective. 
Education of healthcare professionals about this option 
and improved accessibility to programmes is indicated to 
improve clinical outcomes.
CONCLUSIONS
Awareness of the potential benefits of JP, and prior expe-
rience with JP programme were very low. Common poten-
tially modifiable patient- reported barriers to participate 
in future JP interventions, included: cost, work commit-
ments, distance from home to clinic and times that the 
JP intervention were provided. These barriers might be 
addressed with free and accessible forms of delivery of JP, 
which may lead to better uptake and participation in JP.
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Start of Block: "Information about this survey" 
 
Q0 LETTER OF INFORMATION / CONSENTA Study of joint protection for hand arthritis 
exercise preferences in OsteoarthritisPrincipal Investigator: Dr. Joy Christine MacDermid 
(macderj@mcmaster.ca; 519-646-6100 ext. 64636) 
Student Investigator: Leah Catherine Kocherry (kocherlc@mcmaster.ca; 905-525-9140 ext. 
22867)  
Co-Investigator: Pavlos Bobos (pbobos@uwo.ca) 
School of Rehabilitation SciencesMcMaster University Hamilton, Ontario, Canada   Purpose of 
the Study: You are invited to take part in this study about expectations from joint protection and 
preferences for exercise by Leah Kocherry. We want to identify the key expectations and 
preferences for joint protection and the critical barriers and facilitator for exercise in people with 
arthritis. We are hoping to learn how to design better joint protection programs and exercise 
programs. I am doing this research for my Master’s thesis. 
  Procedures involved in the      Research: You will find two questionnaires attached with this 
consent form. You will be asked to complete both questionnaires. The questions will include 
queries about your preferences for exercise and about your thoughts about joint protection. You 
will also be asked questions about your diagnosis and management of arthritis. You will also be 
asked for some demographic/background information like your age and area code. 
  Potential Harms, Risks or      Discomforts: There are no foreseeable risks involved in 
participating in this study. You may feel worried about your responses. There are no right and 
wrong answers and your responses will be kept confidential, so you do not need to worry about 
this. You do not need to answer questions that you do not want to answer or that make you feel 
uncomfortable 
  Potential Benefits We cannot promise any personal benefits to you for your participation in 
this study. The results from this study may benefit society and the scientific community by 
providing health care providers with a better understanding of barriers and facilitators for 
exercise and preferences for joint protection in people with arthritis. 
  Confidentiality Your data will not be shared with anyone except with your consent or as 
required by law. All personal information such as your name and e-mail address will be removed 
from the data and will be replaced with a number. A list linking the number with your name will 
be kept in a secure place separate from your file. The data, with identifying information removed 
will be securely stored in a locked office in the research laboratory.For the purposes of ensuring 
the proper monitoring of the research study, it is possible that a member of the Hamilton 
Integrated Research Ethics Board may consult your research data. However, no records which 
identify you by name or initials will be allowed to leave the hospital. By signing this consent 
form, you or your legally acceptable representative authorizes such access. If the results of the 
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Supplemental material placed on this supplemental material which has been supplied by the author(s) BMJ Open
 doi: 10.1136/bmjopen-2020-041935:e041935. 11 2021;BMJ Open, et al. Bobos P
 
 
 Page 2 of 18 
study are published, your name will not be used and no information that discloses your identity 
will be released or published without your specific consent to the disclosure. 
  Participation and Withdrawal: If you volunteer to be in this study, you may withdraw at any 
time. You have the option of removing your data from the study. You may also refuse to answer 
any questions you don’t want to answer and still remain in the study. The investigator may 
withdraw you from this research if circumstances arise which warrant doing so. 
  Information about the Study      Results: If you would like to receive a summary of this 
study’s results, there is a provision for you to indicate so at the end of the consent form. 
Questions about the Study: If you have questions or need more information about the study 
itself, please contact me at: kocherlc@mcmaster.ca or 905-979-7666 or pbobos@uwo.ca This 
study has been reviewed by the Hamilton Integrated Research Ethics Board (HIREB). The 
HIREB is responsible for ensuring that participants are informed of the risks associated with the 
research, and that participants are free to decide if participation is right for them. If you have any 
questions about your rights as a research participant, please call the Office of the Chair, 
Hamilton Integrated Research Ethics Board at 905.521.2100 x 42013. 
 
o I consent  (4)  
o I do no consent  (5)  
 
Skip To: End of Survey If LETTER OF INFORMATION / CONSENT A Study of joint protection for hand 
arthritis exercise preferenc... = I do no consent 
End of Block: "Information about this survey" 
 
Start of Block: Block 1 
 
Q1 Please select one of the following options 
o I have been diagnosed with hand osteoarthritis  (1)  
o I have been diagnosed with hand rheumatoid arthritis  (2)  
o I have been diagnosed with psoriatic arthritis  (3)  
o I have been diagnosed with some form of arthritis other than hand  (4)  
o None of the above  (5)  
 
Skip To: End of Survey If Please select one of the following options = None of the above 
 
 
BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance
Supplemental material placed on this supplemental material which has been supplied by the author(s) BMJ Open
 doi: 10.1136/bmjopen-2020-041935:e041935. 11 2021;BMJ Open, et al. Bobos P
 
 
 Page 3 of 18 
Q2 Please indicate your age below 
▼ Under 18 (1) ... 85 or older (9) 
 
Skip To: End of Survey If Please indicate your age below = Under 18 
Skip To: End of Survey If Please indicate your age below = 85 or older 
 
 
Q3 Please select one of the four following options 
o I am currently taking part in a joint protection program  (1)  
o I have previously taken part in a joint protection program  (2)  
o I have heard about joint protection but have not taken part in a program  (3)  
o I have not heard about any joint protection programs  (4)  
 
Skip To: End of Block If Please select one of the four following options = I have not heard about any joint 
protection programs 
Skip To: End of Block If Please select one of the four following options = I have heard about joint 
protection but have not taken part in a program 
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Q4 Where did you attend the joint protection program? Check all that apply. 
▢ Inpatient- rehabilitation unit  (1)  
▢ Inpatient- hospital  (2)  
▢ Outpatient- hospital  (3)  
▢ Community recreation center  (4)  
▢ Home care  (5)  
▢ A rehabilitation centre/ clinic  (6)  




Q5 Who provided the joint protection program? (Check all that apply) 
▢ Family physician or specialist  (1)  
▢ Occupational therapist  (2)  
▢ Physiotherapist  (3)  
▢ Hand therapist  (4)  
▢ Kinesiologist  (5)  
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(1)  o  o  o  o  o  o  o  
Pain (2)  
o  o  o  o  o  o  o  
Grip 
strength 
(3)  o  o  o  o  o  o  o  
Hand 
function 
(4)  o  o  o  o  o  o  o  
Swelling 
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Q9 How often did you use joint protection principles after learning them? 
o Not at all  (1)  
o Occasionally (once a week or less)  (2)  
o Quite often (once a week at least)  (3)  











End of Block: Block 1 
 
Start of Block: Block 1 
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Q12 Where did you hear about joint protection program? (Check all that apply) 
▢ From my family physician  (1)  
▢ From my therapist  (2)  
▢ From my specialist (e.g. rheumatologist, surgeon)  (3)  
▢ From my family or friends  (4)  
▢ From newspapers/ television/ internet/ radio  (5)  
▢ From my local community center  (6)  




Q11 Everyone has barriers and facilitators that affect their ability to participate in health 
programs. Please list up to three barriers that might make it difficult for you to participate in a 









Q13 Please list up to three factors that might make it easier for you to participate in a future 
joint protection program. 
________________________________________________________________ 
________________________________________________________________ 
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Q14 To what extent are the following factors a concern that would make it harder for you to 




























close to my 
house (1)  
o  o  o  o  o  o  o  
Transportation 
to the centre 
where 
program is 
provided (2)  
o  o  o  o  o  o  o  
Cost of the 





o  o  o  o  o  o  o  
My work 
commitments 
(6)  o  o  o  o  o  o  o  
My personal 
commitments 
(7)  o  o  o  o  o  o  o  
Support from 
family/friends 




with (9)  




works (10)  





o  o  o  o  o  o  o  
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Q15 Most joint protection programs have pieces that cover:1. Things that affect the loading of 
your joints2. Products that can be used to make tasks easier3. Pacing4. How to organize tasks 
to make it easier for your joints5. Ways to manage symptoms 6. How to get or use helpCovering 
all this information requires about 30 hours of teaching and demonstration. What schedule 
would you prefer for this type of program? Check one. 
o 3 hours, 5 times per week, for 2 weeks  (1)  
o 2 hours, 3 times per week, for 5 weeks  (2)  




Q16 How likely would you be to participate in a program if it is delivered in the following 
formats? Please rank the options below in order of preference (most preferred option at the top). 
Your can slide or place the option in it's order. 
 
 
Your can slide or place the option in it's order. 
______ Online (internet) (1) 
______ Videos (television, DVDs, YouTube etc) (2) 
______ Printed material mailed upon request (pamphlet, guidebook etc) (3) 
______ In clinic (4) 
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Q17 Who would you like to teach you about joint protection? (Check all that apply) 
▢ Family physician or specialist such as rheumatologist  (1)  
▢ Occupational therapist  (2)  
▢ Physiotherapist  (3)  
▢ Hand therapist  (4)  
▢ Kinesiologist  (5)  
▢ Patients  living with arthritis  (6)  
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loading (1)  
o  o  o  o  o  o  o  
Ways to do 
tasks differently 
to reduce joint 
loading (2)  
o  o  o  o  o  o  o  
Feedback on if 
I am doing 
tasks correctly 
(3)  
o  o  o  o  o  o  o  
Information 
about pacing & 
organizing 
activities (4)  





protection (5)  






them (6)  
o  o  o  o  o  o  o  
Demonstrations 
of how to do 
things better (7)  o  o  o  o  o  o  o  
Time to discuss 
tasks that I am 
currently 
having difficulty 
with (8)  
o  o  o  o  o  o  o  
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Sensors that I 
could wear to 




joints (9)  
o  o  o  o  o  o  o  
Information 
about assistive 
tools or devices 
that I could use 
to make daily 
tasks easier 
(10)  
o  o  o  o  o  o  o  
Information 
about where to 
find assistive 
tools or devices 
(11)  



















deformity (1)  o  o  o  o  o  
Reducing 




activity (3)  
o  o  o  o  o  
Maintaining 
grip strength 
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Q20 Would you like someone to contact you to see how you are doing after the joint protection 
program? 
o Yes  (1)  
o No  (2)  
 
Skip To: End of Block If Would you like someone to contact you to see how you are doing after the joint 
protection program? = No 
 
 
Q21 If you were to do it as a web-based program, how would you like to be contacted for follow-
up? Please rank the options below in order of preference (with 1 being your most preferred 
option). Your can slide or place the option in it's order. 
______ Twice per week (1) 
______ Once a week (2) 
______ Once every two weeks (3) 
______ Once early and once at 6 month (4) 




Q22 After a web-based or in-person program, would you like someone to contact you to discuss 
your progress? 
o Yes  (1)  
o No  (2)  
 
Skip To: End of Block If After a web-based or in-person program, would you like someone to contact you 
to discuss your pro... = No 
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Q23 When would you like to be contacted after the completion of the program? 
o After a week  (1)  
o After two weeks  (2)  
o After a month  (3)  
o After two months  (4)  
o Every 6 months  (5)  




Q24 How would you like to be contacted for follow-up? Please rank the options below in order of 
preference (with 1 being your most preferred option). Your can slide or place the option in it's 
order. 
______ By telelphone (1) 
______ By email (2) 




Q25 Whom would you prefer to speak with at your follow-up meeting? Please rank the options 
below in order of preference (with 1 being your most preferred option). Your can slide or place 
the option in it's order. 
______ The person who provided the joint protection program (1) 
______ Another participant from the joint protection program who I had met (2) 
______ Any person living with arthritis who knows about joint protection (3) 
______ Any knowledgeable health professional (4) 
 
End of Block: Block 1 
 
Start of Block: Block 4 
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Q26 Would you participate in web-based forums about joint protection (e.g: Posting boards, 
Facebook groups or email lists)? 
o Yes  (1)  




Q27 How often do you use the following? 











Heat (1)  
o  o  o  o  o  o  
Cold (2)  
o  o  o  o  o  o  
Exercise 
(3)  o  o  o  o  o  o  
Joint 
protection 





devices (5)  
o  o  o  o  o  o  
Splints (6)  
o  o  o  o  o  o  
Modified 
equipment 
(7)  o  o  o  o  o  o  
Other (8)  
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Q28 Have you had surgery because of your arthritis? 
o If yes please specify type of surgery  (1) 
________________________________________________ 
o No  (2)  
 
Skip To: End of Block If Have you had surgery because of your arthritis? = No 
End of Block: Block 4 
 
Start of Block: Block 4 
 
Q29 How often do you use your medication? 
o Daily  (1)  
o When you feel pain  (2)  




Q30 Is there anything you would like us to know as we work on developing a new joint 
protection program for people with hand arthritis? 
o Yes  (8) ________________________________________________ 




Q31 We are planning to develop a new joint protection program that would be updated and 
based on patient input.  Would you be interested in participating in the following? (Check all that 
apply) 
▢ Helping develop a new joint protection program  (1)  
▢ Participating in a study of a new joint protection program  (2)  
▢ Being a learner after the joint protection program has been tested  (3)  
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Q32 If you would like to be contacted about the above, how would you prefer to be contacted? 
o By telephone  (1) ________________________________________________ 
o By post  (2) ________________________________________________ 




Q33 Would you like to receive a summary of the results this survey          
o If yes, please provide your email  (1) 
________________________________________________ 
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